相关实验视频

Updated: May 25, 2025

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

优化对抗卡巴胺耐药 Enterobacter cloacae 细菌病的菌体疗法:对剂量和时间的洞察

Shi-Yong Fu¹, Xiu-Zhen Chen², Peng-Cheng Yi²

¹Department of Oncology, the Second Hospital of Nanjing, Affiliated Hospital to Nanjing University of Chinese Medicine, Nanjing, China.

Antimicrobial agents and chemotherapy

|February 26, 2025

概括

新型菌体有效治疗多药耐药的Enterobacter cloacae复杂感染. 优化菌体尾酒的剂量和时间,包括预防性使用,对于对抗抗卡巴胺耐药细菌感染至关重要.

科学领域:

微生物学微生物学
细菌学细菌学是一门学科.
菌体疗法是一种菌体疗法.

背景情况:

越来越多的多药耐药性 (MDR) 感染,尤其是耐卡巴胺菌株.
迫切需要除了传统抗生素之外的替代治疗策略.
具有良好的特征的ECC向菌体的有限可用性和菌体尾酒的尚未探索的剂量/时间.

研究的目的:

隔离和描述针对ECC的新型菌体.
在小鼠模型中评估菌体尾酒对E.cloacae细菌病的疗效.
研究菌体剂量和给药时间对治疗结果的影响.

主要方法:

三种新型菌体的隔离和特征.
菌体宿主范围的评估,包括FEBU8对肠杆菌物种和Acinetobacter baumannii的活性.
评估FECL22的稳定性 (温度,pH) 和受体识别 (OmpA).
在体内使用E.cloacae细菌病与菌体尾酒的小鼠模型进行的疗效研究 (ФEBU8, ФECL22, ФECL30).

主要成果:

三种新型的菌体被隔离和特征化.
ФEBU8显示了广谱活性; ФECL22表现出稳定性和19个PFU/细胞的爆裂大小.
菌体尾酒在拯救患有E.cloacae bacteremia的小鼠方面表现出剂量依赖的疗效.
立即和预防/治疗 (-24 + 6) 治疗方案实现了100%的存活率.

结论:

剂量和时间是优化对抗卡巴胺耐药 Enterobacter 感染的菌体治疗的关键因素.
预防性菌体管理提供了一个重要的治疗窗口和一个有前途的战略.
新型菌体和优化的菌体尾酒代表了严重细菌感染的可行替代方案.

关键词:

杆菌cloacae复杂的杆菌.这就是OmpaA.剂量优化剂量优化主机范围的主机范围.菌体疗法是一种菌体疗法.预防性使用预防性使用接收器接收器接收器接收器

更多相关视频

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

相关概念视频

Lytic Cycle of Bacteriophages

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...

Antibiotic Selection

Antibiotic Selection

Lysogenic Cycle of Bacteriophages

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...